Dr. Adrienne Waks, MD
Claim this profileDana Farber Cancer Institite
Studies Breast Cancer
Studies Breast cancer
7 reported clinical trials
14 drugs studied
Area of expertise
1Breast Cancer
HER2 positive
ER positive
Stage IV
2Breast Cancer
HER2 positive
ER positive
ER negative
Affiliated Hospitals
Clinical Trials Adrienne Waks, MD is currently running
Triple Drug Combo
for Breast Cancer
This research is being done to evaluate the safety and effectiveness of a drug currently known as VS-6766 in combination with the drugs abemaciclib and fulvestrant in HR+/HER2-negative breast cancer. The names of the study drugs involved in this study are: * VS-6766 * Abemaciclib * Fulvestrant
Recruiting1 award Phase 1 & 214 criteria
Sacituzumab Govitecan + Trastuzumab
for Breast Cancer
This research study is being done to evaluate the safety and effectiveness of sacituzumab govitecan with trastuzumab (Herceptin, Herceptin Hylecta, or trastuzumab biosimilar) in metastatic HER2+ breast cancer. The names of the study drugs used in this research study are: * Sacituzumab govitecan (a type of antibody-drug conjugate) * Trastuzumab (Herceptin) (a type of monoclonal antibody) * Trastuzumab and Hyaluronidase-oysk (Herceptin Hylecta) (a type of recombinant monoclonal antibody) * Trastuzumab biosimilar drug
Recruiting1 award Phase 218 criteria
More about Adrienne Waks, MD
Clinical Trial Related2 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Adrienne Waks, MD has experience with
- Trastuzumab
- Pertuzumab
- Paclitaxel
- Abemaciclib
- Fulvestrant
- VS-6766
Breakdown of trials Adrienne Waks, MD has run
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Adrienne Waks, MD specialize in?
Adrienne Waks, MD focuses on Breast Cancer and Breast cancer. In particular, much of their work with Breast Cancer has involved HER2 positive patients, or patients who are ER positive.
Is Adrienne Waks, MD currently recruiting for clinical trials?
Yes, Adrienne Waks, MD is currently recruiting for 3 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Adrienne Waks, MD has studied deeply?
Yes, Adrienne Waks, MD has studied treatments such as Trastuzumab, Pertuzumab, Paclitaxel.
What is the best way to schedule an appointment with Adrienne Waks, MD?
Apply for one of the trials that Adrienne Waks, MD is conducting.
What is the office address of Adrienne Waks, MD?
The office of Adrienne Waks, MD is located at: Dana Farber Cancer Institite, Boston, Massachusetts 02215 United States. This is the address for their practice at the Dana Farber Cancer Institite.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.